By browsing our site you agree to our use of cookies. You will only see this message once. Find out more

Supply of Bosentan 62.5mg and 125mg tablets to Health Boards across NHS Scotland. The goods were grouped together in to 1 Lot. Full details are contained in section II.2 of this notice.

Contract award notice

Results of the procurement procedure

Supplies

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Gyle Square (NSS Head Office), 1 South Gyle Crescent
Edinburgh
EH12 9EB
United Kingdom
Contact person: Stephanie McNiven
Telephone: +44 1698794410
E-mail:
NUTS code: UKM

Internet address(es):

Main address: http://www.nhsscotlandprocurement.scot.nhs.uk/

Address of the buyer profile: http://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883

I.2)Joint procurement
The contract is awarded by a central purchasing body
I.4)Type of the contracting authority
Body governed by public law
I.5)Main activity
Health

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Bosentan.

Reference number: NP46917
II.1.2)Main CPV code
33600000
II.1.3)Type of contract
Supplies
II.1.4)Short description:

Supply of Bosentan 62.5mg and 125mg tablets to Health Boards across NHS Scotland.

The goods were grouped together in to 1 Lot.

Full details are contained in section II.2 of this notice.

II.1.6)Information about lots
This contract is divided into lots: no
II.1.7)Total value of the procurement (excluding VAT)
Value excluding VAT: 220 000.00 GBP
II.2)Description
II.2.1)Title:
II.2.2)Additional CPV code(s)
33600000
II.2.3)Place of performance
NUTS code: UK
Main site or place of performance:

All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.

II.2.4)Description of the procurement:

This framework agreement is for the supply of Bosentan 62.5mg and 125mg tablets to NHS Scotland. Product lines included were grouped together into one lot as the requirement.

Supply of the medicine is required direct to hospitals and nominated home delivery supplier(s) as directed by the Authority.

The Authority has awarded a single-supplier framework agreement for the requirement.

II.2.5)Award criteria
Quality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section IV: Procedure

IV.1)Description
IV.1.1)Type of procedure
Open procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
IV.1.6)Information about electronic auction
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure
Notice number in the OJ S: 2017/S 097-191257
IV.2.8)Information about termination of dynamic purchasing system
IV.2.9)Information about termination of call for competition in the form of a prior information notice

Section V: Award of contract

Contract No: NP46917
A contract/lot is awarded: yes
V.2)Award of contract
V.2.1)Date of conclusion of the contract:
28/07/2017
V.2.2)Information about tenders
Number of tenders received: 7
The contract has been awarded to a group of economic operators: no
V.2.3)Name and address of the contractor
Milpharm Limited
Ares, Odyssey Business Park, West End Road
South Ruislip
HA4 6QD
United Kingdom
Telephone: +44 2088458811
Fax: +44 20884588795
NUTS code: UK
The contractor is an SME: no
V.2.4)Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot: 220 000.00 GBP
V.2.5)Information about subcontracting

Section VI: Complementary information

VI.3)Additional information:

The estimated values referred to in Sections II.I.7 and V.2.4 cover the twenty-three (23) month contract duration and the twelve (12) month extension period of the framework agreement.

(SC Ref:508577).

VI.4)Procedures for review
VI.4.1)Review body
The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Gyle Square (NSS Head Office), 1 South Gyle Crescent
Edinburgh
EH12 9EB
United Kingdom
Telephone: +44 1698794410

Internet address:http://www.nhsscotlandprocurement.scot.nhs.uk/

VI.4.2)Body responsible for mediation procedures
VI.4.3)Review procedure
Precise information on deadline(s) for review procedures:

The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.

VI.4.4)Service from which information about the review procedure may be obtained
VI.5)Date of dispatch of this notice:
18/08/2017